Stockscreener 앱 받기
10.14
2.31%
-0.24
Fulcrum Therapeutics Inc 주식(FULC)의 최신 뉴스
Insider Sell: Is Canadian Imperial Bank of Commerces growth already priced in2025 Stock Rankings & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Block Trades: Is Fulcrum Therapeutics Inc part of any ETF2025 Fundamental Recap & Real-Time Volume Triggers - baoquankhu1.vn
Can Fulcrum Therapeutics Inc. disrupt its industryWeekly Trading Summary & Free Low Drawdown Momentum Trade Ideas - bollywoodhelpline.com
Fulcrum Therapeutics (NASDAQ:FULC) Shares Up 7.8%What's Next? - MarketBeat
Whale Trades: Is Fulcrum Therapeutics Inc stock dividend yield sustainable2025 Investor Takeaways & Daily Profit Maximizing Tips - Bộ Nội Vụ
Gains Recap: Whats the fair value of Fulcrum Therapeutics Inc stock2025 Valuation Update & Safe Capital Growth Plans - baoquankhu1.vn
Fulcrum Therapeutics (NASDAQ:FULC) Coverage Initiated by Analysts at JPMorgan Chase & Co. - Defense World
Performance Recap: Can Fulcrum Therapeutics Inc keep up with sector leaders2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
JP Morgan Initiates Coverage of Fulcrum Therapeutics (FULC) with Overweight Recommendation - Nasdaq
Fulcrum Therapeutics (NASDAQ:FULC) Shares Gap UpShould You Buy? - MarketBeat
This Netflix Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
JPMorgan Initiates Coverage on Fulcrum Therapeutics With Overweight Rating, $20 Price Target - marketscreener.com
Wall Street analysts think Fulcrum Therapeutics (FULC) could surge 58.47%: Read this before placing a bet - MSN
Can Fulcrum Therapeutics Inc. stock beat market expectations this quarterFootwear buying guidance for consistent weekly training mileage focuses on stable support and balance, making it a solid option for daily use. - ulpravda.ru
How Fulcrum Therapeutics Inc. stock performs in stagflation2025 Market Sentiment & Verified Entry Point Signals - Улправда
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Star TribuneFulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - FinancialContent
Can Fulcrum Therapeutics Inc. stock surprise with earnings upside2025 Volume Leaders & Stock Timing and Entry Methods - Улправда
Will Fulcrum Therapeutics Inc. stock outperform Dow Jones indexWeekly Profit Report & Long-Term Capital Growth Strategies - Улправда
How geopolitical tensions affect Fulcrum Therapeutics Inc. stock2025 Biggest Moves & Pattern Based Trade Signal System - Улправда
Will Fulcrum Therapeutics Inc. stock benefit from AI adoptionPrice Action & Community Trade Idea Sharing Platform - Улправда
Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: A Biotech With A 90% Upside Potential - DirectorsTalk Interviews
Fulcrum Therapeutics shares rise after positive phase 1b sickle cell trial results - MSN
Why Fulcrum Therapeutics Inc. stock is a must watch in 2025Currency Fluctuation Impact & Consistent Triple Returns - Улправда
Fulcrum Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
2026 world cup results breakdown: Is Fulcrum Therapeutics Inc. stock supported by strong cash flows2026 world cup usa national team round of 32 playmakers pressing system odds analysis expert opinion - ulpravda.ru
Fulcrum Therapeutics (NASDAQ:FULC) Stock Price Down 5.4%Should You Sell? - MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Sees Significant Decrease in Short Interest - MarketBeat
Fulcrum Therapeutics (NASDAQ:FULC) Trading Down 4.3%Time to Sell? - MarketBeat
Wall Street Analysts Think Fulcrum Therapeutics (FULC) Could Surge 58.47%: Read This Before Placing a Bet - Yahoo Finance
Fulcrum Therapeutics (NASDAQ:FULC) Shares Up 3%Should You Buy? - MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Given Consensus Rating of “Hold” by Analysts - Defense World
Fulcrum Therapeutics Earnings Notes - Trefis
Fulcrum Therapeutics (NASDAQ:FULC) Shares Down 5.7%Should You Sell? - MarketBeat
RBC Capital maintains Fulcrum Therapeutics (FULC) sector perform recommendation - MSN
Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study - Insider Monkey
Fulcrum Therapeutics (FULC) Price Target Increased by 32.56% to 19.38 - Nasdaq
Retail Trends: Why Fulcrum Therapeutics Inc stock is a must watch in 20252025 Investor Takeaways & High Yield Stock Recommendations - moha.gov.vn
FULC (Fulcrum Therapeutics) Price-to-Tangible-Book : 3.35 (As of Dec. 20, 2025) - GuruFocus
What makes Fulcrum Therapeutics Inc. stock attractive to growth fundsJuly 2025 Selloffs & Safe Entry Point Alerts - Улправда
Why Fulcrum Therapeutics Inc. stock is considered a top pick2025 Retail Activity & Free Technical Pattern Based Buy Signals - Улправда
Is Fulcrum Therapeutics Inc. stock undervalued vs historical averages2025 Performance Recap & Community Driven Trade Alerts - Улправда
Retail Trends: Why Fulcrum Therapeutics Inc. stock is a must watch in 2025 - Улправда
Published on: 2025-12-19 18:03:13 - DonanımHaber
Can Fulcrum Therapeutics Inc. stock deliver consistent earnings growthQuarterly Performance Summary & High Win Rate Trade Tips - DonanımHaber
[Form 4] Fulcrum Therapeutics, Inc. Insider Trading Activity - Stock Titan
Market Trends: Will Fulcrum Therapeutics Inc. stock attract more institutional investorsWeekly Investment Report & Technical Entry and Exit Tips - Улправда
Insider Sell: Curtis Oltmans Sells Shares of Fulcrum Therapeutics Inc (FULC) - GuruFocus
Fulcrum Therapeutics Chief Legal Officer Sells Shares - TradingView — Track All Markets
B of A Securities maintains Fulcrum Therapeutics (FULC) underperform recommendation - MSN
Fulcrum Therapeutics (NASDAQ:FULC) Rating Increased to Hold at Wall Street Zen - MarketBeat
Firmware Signing Platform Market Size to Reach USD 6.29 Billion by 2033 | Report by SNS Insider - GlobeNewswire Inc.
Ra Capital Management, L.P. Sells 4,175,139 Shares of Fulcrum Therapeutics (NASDAQ:FULC) Stock - Defense World
4.73%
0.92%
자본화:
|
볼륨(24시간):